Patent · US Active

Cyano containing azabenzofuran compounds for the treatment of hepatitis C

US9249152B2 · kind B2 · utility

0Cited by

3References

23Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

Tao Wang · Farmington, US
Kyle J. Eastman · New Haven, US
Zhongxing Zhang · Wallingford, US
Kyle E. Parcella · Wallingford, US
Zhiwei Yin · Glastonbury, US
John F. Kadow · Wallingford, US

Key dates

Filing date	Mar 20, 2015
Grant date	Feb 2, 2016
Priority date	—
Expiry date	Mar 20, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D491/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of Formula I, including their salts, as well as compositions and methods of using the compounds are set forth. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.